[Form 4] RB GLOBAL INC. Insider Trading Activity
Rhea-AI Filing Summary
Insider Form 4 summary for RB Global Inc. (RBA)
Christopher Carlson, Chief Accounting Officer, reported acquisitions of dividend equivalent rights tied to restricted share unit grants. On 09/18/2025 he acquired 3 dividend equivalent rights related to 2023 RSUs, 6 related to 2024 RSUs, and 3 related to 2025 RSUs, representing the contingent economic equivalent of the indicated number of RBA common shares. After these transactions he beneficially owns 36, 54, and 6 shares attributable to each respective grant, reported as direct ownership. The form was signed by an attorney-in-fact on 09/22/2025.
Positive
- Timely disclosure of insider transactions under Section 16 is provided
- Clear explanation that dividend equivalent rights are contingent and vest with underlying RSUs
- Direct beneficial ownership amounts are reported for each RSU grant series
Negative
- None.
Insights
TL;DR: Officer reported small acquisitions of dividend-equivalent rights tied to RSUs; disclosure is routine and non-material on its face.
The filing documents accrued dividend equivalent rights for three separate RSU grants (2023, 2024, 2025) with modest share equivalents (3, 6, 3). These rights are contingent payments that vest proportionately with the underlying RSUs and carry a stated economic equivalence to common shares at a $0 price. The report shows direct beneficial ownership figures for each grant series rather than transfers or sales. There is no disclosure in this form of cash considerations, option exercises, or changes to compensation arrangements beyond the accrual of dividend equivalents.
TL;DR: Filing reflects routine insider compensation accruals and timely Section 16 reporting; no governance red flags are evident in the filing alone.
The Form 4 indicates standard reporting of dividend equivalent rights associated with previously granted RSUs. The descriptor clarifies the rights become exercisable proportionately with the underlying RSUs, which is consistent with common equity compensation practices. The form is signed by an authorized attorney-in-fact, documenting compliance with signature requirements. No departures from standard disclosure practice are shown in this filing.